University of Cincinnati Cancer Center researchers led a first-of-a-kind clinical study showing that a cancer treatment known ...

Considering they’re a class of drugs known for making you smaller, GLP-1 receptor agonists are only getting bigger. As many ...

A 2026 University of Münster study found that immature granulocyte count in a routine blood test predicts 30-day heart attack ...

I'm currently in the final stages of recovering from osteonecrosis of the jaw (ONJ). Getting a diagnosis took two months, all ...

An Alabama teen flew to Los Angeles for life-saving treatment in his fight with stage four bone cancer after the Trump administration stepped in to help. Will Roberts, 15, made a plea for help on his ...

Every year, more than 200,000 people in Germany suffer a heart attack. This is caused by blocked coronary arteries. As a result, part of the heart muscle is no longer supplied with sufficient blood ...

With funding from ARPA-H, three teams of researchers have regrown bone and cartilage, even entire knees, in animal studies. Human trials are not far off. By Gina Kolata Three years ago, a little-known ...

Scientists have identified a little-known receptor, GPR133, as a powerful regulator of bone strength. By activating it with a newly discovered compound called AP503, they were able to boost bone ...

Hormonal suppression therapies for endometriosis, such as gonadotropin-releasing hormone (GnRH) agonists with add-back therapy, dienogest, and GnRH antagonists, were associated with reductions in bone ...

On her best days, Tatyana Thompson’s pain was at a level five. Some days, it would stay that way, a persistent throb in her joints, her hands, her back. On other days, if she was dehydrated or was hit ...

Feb 5 (Reuters) - (This Feb 5 story has been corrected to fix Prolia's 2025 sales to $4.4 billion, not $1.05 billion, in paragraph 5) Sign up here. Its pharmacy benefit management unit, Caremark, will ...